###
中国临床研究:2026,39(10):1617-1621
本文二维码信息
码上扫一扫!
脑心综合征的新机制、生物标志物及治疗新策略
杨梦娉1, 李家立2, 陈雪英3,4,5,6, 王芬3,4,5,6, 孙忠旭1, 林楠3,4,5,6
(1. 济宁医学院临床医学院,山东 济宁 272067;2. 济宁医学院附属医院中医科,山东 济宁 272001;3. 济宁医学院附属医院心内科,山东 济宁 272001;4. 济宁医学院附属医院山东省重点医学与健康学科——心脏病学,山东 济宁 272001;5. 济宁医学院附属医院山东省重点医学与健康实验室——心血管疾病诊疗,山东 济宁 272001;6.6. 济宁市冠状动脉介入精准治疗重点实验室,山东 济宁 272001)
New mechanisms,biomarkers and therapeutic strategies for cerebrocardiac syndrome
摘要
本文已被:浏览 218次   下载 227次
投稿时间:2026-02-10   网络发布日期:2026-10-23
中文摘要: 脑心综合征(CCS)又称卒中-心脏综合征,其本质是脑部疾病与心脏功能相互作用的复杂临床综合征。近年来,随着对CCS机制的深入探索,新的病理生理机制如肠道菌群-脑-心轴、中性粒细胞胞外陷阱(NETs)及线粒体自噬异常等被发现,为CCS的临床治疗提供了新思路。由于脑部病变症状易掩盖心脏的异常、缺乏特异性诊断指标,且患者常合并心脑血管基础病导致鉴别困难,临床实践中对CCS机制认知尚不充分,诊断缺乏统一标准,治疗手段相对有限。本文从CCS的病理生理机制、诊断及治疗等方面对CCS的研究进展进行系统综述。
Abstract:Cerebrocardiac syndrome(CCS),also known as stroke-heart syndrome,is a complex clinical syndrome defined by the pathophysiological interactions between cerebral disorders and cardiac function. In recent years,in-depth investigations into CCS mechanisms have identified novel pathophysiological pathways,including the gut microbiota-brain-heart axis,neutrophil extracellular traps(NETs)and abnormal mitophagy,providing new insights for the clinical management of CCS. The diagnosis of CCS remains challenging in clinical practice:neurological symptoms frequently overshadow cardiac abnormalities,specific diagnostic biomarkers are lacking,and pre-existing cardiovascular and cerebrovascular comorbidities further complicate differential diagnosis. In addition,clinical understanding of CCS mechanisms is still insufficient,unified diagnostic criteria have not been established,and therapeutic options remain relatively limited. This article presents a systematic review of research advances in CCS,covering its pathophysiological mechanisms,diagnostic strategies and therapeutic modalities.
文章编号:     中图分类号:R541 R743    文献标志码:A
基金项目:山东省自然科学基金项目(ZR2024MH098);山东省中医药科技项目(ZR20244405);济宁市重点研发计划 (2024YXNS238)
附件
引用文本:
杨梦娉,李家立,陈雪英,等.脑心综合征的新机制、生物标志物及治疗新策略[J].中国临床研究,2026,39(10):1617-1621.

用微信扫一扫

用微信扫一扫